Similar to ROR1, ROR2 supported proliferation and tumor growth, while inhibiting apoptosis both in vitro as well as in vivo in mouse models of osteosarcoma, breast and renal cancer [44,89,90,91]. Here, ROR2 is linked to renal carcinoma.